In order to gain a fuller understanding of ghrelin’s role in modulating both inflammatory processes and depressive symptoms in the context of obesity, integrated clinical studies considering all these aspects are needed. The gene discussed is GHRL; the disease is obesity due to melanocortin 4 receptor deficiency.